CHMFL-BMX-078, a BMX inhibitor, overcomes the resistance of melanoma to vemurafenib via inhibiting AKT pathway.
Chem Biol Interact. 2022 Jan 5;351:109747. doi: 10.1016/j.cbi.2021.109747. Epub 2021 Nov 20.
Chem Biol Interact. 2022.
PMID: 34813779